Effects of Bolus Surfactant Therapy on Peripheral Perfusion Index and Tissue Carbon Monoxide
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Exogenous bolus surfactant administration may affect hemodynamic parameters and peripheral
perfusion. Surfactant therapy is commonly used for respiratory distress syndrome in premature
infants, which is also associated with inflammation. There are different types and doses of
surfactant preparations available. With the help of new generation monitors, changes in
peripheral perfusion and transcutaneous CO, a marker of inflammation, may be demonstrated.